The threshold for the sympathetic and hormonal counterregulatory response is generally elevated in patients with type 2 diabetes (30, 31), whereas the counterregulatory threshold is normalized when insulin therapy is initiated (32). The gene discussed is INS; the disease is type 2 diabetes mellitus.